Home / Inspections / 1132410

FDA Inspection 1132410 — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc — FEI 3009518416

The FDA completed an inspection of Ascent Pharmaceuticals Inc on October 13, 2020 in Central Islip, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 13, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Central Islip, NY (United States)

Facility

Other inspections at this facility

  • 1229681 (VAI Fri Aug 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1179615 (VAI Thu Sep 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1074882 (NAI Wed Nov 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067030 (NAI Fri Jul 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1047500 (NAI Wed Feb 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources